相关实验视频
Updated: Jul 24, 2025
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.7K
在对抗性甲状腺癌管理的近期进展
Sarah Hamidi1, Anastasios Maniakas2
1Department of Endocrine Neoplasia and Hormonal Disorders.
概括
最近甲状腺癌 (ATC) 的进展包括BRAFV600E突变的新分类和向疗法. 虽然有希望,但抗药性和对非突变病例的治疗等挑战仍然存在.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种罕见且激进的甲状腺癌形式.
- 最近的世卫组织分类更新包括状细胞癌作为ATC的亚型.
- 通过下一代测序 (NGS) 进行分子分析,提高了对ATC的理解和预测.
结论:
- 在特征和管理ATC方面取得了重大进展,特别是在BRAFV600E突变病例中.
- 对ATC的治愈治疗仍然难以捉摸,在对当前疗法的耐药性方面,选择有限.
- 需要进一步的研究,以开发有效的治疗方法,为非BRAF突变的ATC.患者.
相关概念视频
01:27Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K